Competition Law and the Pharmaceutical Sector in India

IIMA Institutional Repository

Please use this identifier to cite or link to this item: http://hdl.handle.net/11718/17052

Full metadata record

DC Field	Value	Language
dc.contributor.author	Mondal, Shamim S.
dc.contributor.author	Pingali, Viswanath
dc.date.accessioned	2015-12-18T07:13:26Z
dc.date.available	2015-12-18T07:13:26Z
dc.date.copyright	2015
dc.date.issued	2015
dc.identifier.uri	http://hdl.handle.net/11718/17052
dc.description.abstract	The Indian pharmaceutical industry is one of the largest in the world both in terms of volume and value. Given its critical importance, the sector has been subject to a series of regulatory interventions, which have altered the nature of the industry quite significantly. With enacting the Indian competition Act (2002), India has joined the list of countries that has a robust competition regime. The purpose of this chapter is to understand the pharmaceutical sector through the prism of competition law.	en_US
dc.language.iso	en	en_US
dc.publisher	Indian Institute of Management Ahmedabad	en_US
dc.relation.ispartofseries	WP;20151102
dc.subject	Competition Law	en_US
dc.subject	Pharmaceutical Sector	en_US
dc.title	Competition Law and the Pharmaceutical Sector in India	en_US
dc.type	Working Paper	en_US
Appears in Collections:	Working Papers

Files in This Item:

File	Description	Size	Format
Pingali2015.pdf		941.28 kB	Adobe PDF	View/Open